Remote | ADC & Bispecific Antibody R&D Scientist — $50–$90/hour

24-Mag

  • New York, New York
  • 20 days ago
  • Remote

    Highlights

    Selected experts will review scientific materials and programme data, evaluate technical outputs, contribute practical judgement on modality and development decisions, and help define high-quality data structures grounded in authentic ADC and bispecific R&D workflows. We are sharing a specialised part-time consulting opportunity for experienced preclinical R&D scientists with hands-on expertise in antibody-drug conjugates (ADCs), bispecific or multispecific antibodies, and in-house drug development.

    Numbers & Facts

    LocationNew York, New York (
    Remote
    )
    Website4-mag.com/privacy-policy

    Description

    We are sharing a specialised part-time consulting opportunity for experienced preclinical R&D scientists with hands-on expertise in antibody-drug conjugates (ADCs), bispecific or multispecific antibodies, and in-house drug development.

    This role supports a research initiative focused on improving how advanced computational systems reason about real-world biologics discovery and preclinical development. Selected experts will review scientific materials and programme data, evaluate technical outputs, contribute practical judgement on modality and development decisions, and help define high-quality data structures grounded in authentic ADC and bispecific R&D workflows.

    Key Responsibilities

    ADC & Bispecific Programme Review

    • Review technical materials and scientific data from ADC, bispecific, and multispecific antibody programmes
    • Evaluate whether analyses and conclusions reflect realistic preclinical development practice
    • Identify weak assumptions, unsupported claims, and biologically implausible outputs
    • Apply hands-on programme experience to complex development scenarios
    • Assess trade-offs involving efficacy, safety, developability, manufacturability, and programme risk

    Target & Modality Strategy

    • Evaluate target-selection and modality-selection decisions
    • Assess biological rationale, therapeutic hypothesis, and competitive differentiation
    • Review trade-offs between ADC, bispecific, multispecific, and other biologic approaches
    • Identify risks associated with target biology, expression patterns, mechanism of action, or therapeutic window
    • Apply practical judgement to programme progression and prioritisation decisions

    ADC Development

    • Contribute expertise across antibody selection, linker strategy, payload choice, conjugation, and overall ADC design
    • Evaluate potency, selectivity, internalisation, stability, exposure, and toxicity considerations
    • Review development decisions affecting efficacy and therapeutic index
    • Assess preclinical evidence supporting candidate progression
    • Identify common failure modes and optimisation challenges in ADC programmes

    Bispecific & Multispecific Antibodies

    • Review programmes involving bispecific or multispecific antibody architectures
    • Evaluate target combinations, binding strategy, format selection, and functional activity
    • Assess developability, PK/PD, immunogenicity, safety, and manufacturability considerations
    • Review translational evidence and candidate-selection decisions
    • Identify modality-specific risks that may affect progression toward the clinic

    Preclinical & Translational Development

    • Apply experience across in vitro, in vivo, translational, pharmacology, and PK/PD workflows
    • Evaluate experimental design and interpretation of preclinical evidence
    • Assess how findings influence candidate optimisation and development strategy
    • Review programme readiness for lead optimisation or IND-enabling development
    • Identify evidence gaps, unresolved risks, and appropriate next-stage studies

    Cross-Functional R&D Expertise

    • Contribute expertise from areas such as:
      • Discovery biology
      • Medicinal chemistry
      • Protein and antibody engineering
      • Computational drug discovery
      • In vivo and translational research
      • Pharmacology and PK/PD
      • Toxicology
      • CMC and formulation
    • Apply cross-functional judgement to integrated programme decisions
    • Evaluate how findings from different disciplines affect candidate selection and development

    Scientific Data Evaluation

    • Label, classify, and annotate scientific data and technical outputs
    • Identify meaningful experimental signals, development decisions, and failure modes
    • Evaluate the relevance and quality of information used in downstream research workflows
    • Help establish consistent standards for scientific review and annotation
    • Translate practical R&D expertise into structured, usable data

    Dataset & Research Development

    • Help define structure and quality standards for scientific data pipelines
    • Identify which experimental and development variables should be captured
    • Surface workflow details that are often missed outside hands-on preclinical R&D
    • Participate in expert discussions, interviews, and research engagements
    • Provide practical perspective on how biologics programmes are advanced in industry

    Ideal Profile

    • 5+ years of relevant pharmaceutical or biotechnology R&D experience, with flexibility for candidates demonstrating exceptional technical depth
    • Hands-on, non-administrative preclinical R&D experience within a company developing its own therapeutic assets
    • Direct professional experience with ADCs and/or bispecific or multispecific antibodies
    • Experience at an organisation that has advanced internal drug programmes toward or into clinical development
    • Current or recent work in a core R&D function such as discovery biology, medicinal chemistry, protein or antibody engineering, computational discovery, translational science, pharmacology, PK/PD, toxicology, or CMC
    • Strong understanding of biologics discovery, optimisation, and preclinical development
    • Experience advancing a programme through lead optimisation, IND-enabling studies, or preclinical development is highly valued
    • Experience within mid-sized, emerging, or resource-constrained biotechnology environments is advantageous
    • Seniority may range from experienced individual contributor through Director level
    • Strong scientific judgement and ability to explain development decisions clearly
    • This opportunity is best suited to hands-on drug-development professionals rather than backgrounds focused primarily on CRO/CDMO services, academic-only research, QC/analytical functions, clinical development, diagnostics, regulatory affairs, or medical writing

    Engagement Details

    • Part-time independent contractor engagement
    • Fully remote
    • Expected commitment of approximately 10 hours per week
    • Ongoing engagement based on project needs
    • Compensation: $50–$90/hour
    • Contributors will interact directly with the assigned research team
    • Projects may be extended, shortened, or concluded based on project needs and performance
    • Work must be completed without using confidential or proprietary information belonging to any employer, client, institution, or other third party
    • H1-B and STEM OPT support is unavailable for this engagement

    About the Platform

    This opportunity is available through 24-MAG LLC. We connect experienced professionals with remote consulting opportunities across technical, evaluation, and project-based workstreams.

    By submitting this application, you acknowledge that your information may be processed by 24-MAG LLC for recruitment and opportunity matching in accordance with our Privacy Policy: https://www.24-mag.com/privacy-policy.

    Similar Jobs

    See more jobs